Do Not Reduce Your Telmisartan Dose
Your blood pressure of 120-126/65 mmHg is well-controlled and within optimal target range; reducing telmisartan would likely worsen your BP control and increase cardiovascular risk. Your dizziness requires evaluation for other causes rather than dose reduction.
Why Your Current BP is Appropriate
Your systolic BP of 120-126 mmHg falls within the optimal treatment target of 120-129 mmHg recommended by the most recent 2025 AHA/ACC guidelines 1. The 2024 ESC guidelines similarly recommend targeting systolic BP to 120-129 mmHg in most treated patients 2. Your diastolic BP of 65 mmHg, while on the lower end, is not concerning unless you have specific symptoms clearly related to hypotension.
The combination of telmisartan 40 mg plus amlodipine 5 mg is a guideline-recommended first-line combination - specifically, an ARB (angiotensin receptor blocker) with a dihydropyridine calcium channel blocker 3, 4, 2. This is one of the preferred two-drug combinations for hypertension management.
Addressing Your Dizziness
Intermittent dizziness with your BP readings does not automatically indicate overtreatment. Here's what to evaluate:
Orthostatic Hypotension Assessment
- Measure BP lying down, then immediately upon standing, and again at 1 and 3 minutes
- A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic indicates orthostatic hypotension
- If present, this may warrant medication adjustment, but reduce amlodipine first, not telmisartan (calcium channel blockers are more likely to cause orthostatic symptoms)
Other Causes to Exclude
- Dehydration or volume depletion - ensure adequate fluid intake
- Timing of symptoms - does dizziness occur specifically after taking medications, or is it unrelated?
- Vestibular disorders - inner ear problems causing positional dizziness
- Medication side effects from other drugs you may be taking
- Metabolic issues - check blood glucose, electrolytes (particularly potassium with telmisartan 5)
Why Telmisartan Should Not Be Reduced
The FDA-approved dosing for telmisartan in hypertension is 40-80 mg once daily, with most antihypertensive effect apparent within 2 weeks and maximal reduction at 4 weeks 5. Your current 40 mg dose is the standard starting dose, not a high dose.
Reducing telmisartan to 20 mg would:
- Provide suboptimal BP control (20 mg produces only 6-8/6 mmHg reduction vs 9-13/6-8 mmHg with 40 mg 5)
- Increase your cardiovascular risk by allowing BP to rise above target
- Potentially require adding back the dose later, creating unnecessary medication changes
The Correct Approach If Adjustment Is Needed
If dizziness is truly medication-related and orthostatic hypotension is confirmed:
First step: Reduce amlodipine from 5 mg to 2.5 mg - calcium channel blockers are more commonly associated with dizziness and peripheral edema than ARBs 6, 7
Monitor BP for 2 weeks - ensure it remains <140/90 mmHg (absolute minimum threshold)
Only if BP remains well-controlled at <130/80 mmHg on reduced amlodipine, consider whether further adjustment is needed
Never reduce telmisartan below 40 mg - this is the minimum effective dose for cardiovascular protection
Key Monitoring Points
- Check serum potassium - telmisartan can cause hyperkalemia, particularly with renal impairment 5
- Assess renal function - ensure creatinine is stable
- Home BP monitoring - measure BP twice daily (morning and evening) to confirm office readings
- Document timing of dizziness - keep a symptom diary to identify patterns
Common Pitfall to Avoid
Do not assume that "lower BP = medication reduction needed." Your BP of 120-126/65 mmHg represents optimal control that reduces cardiovascular events and mortality 1, 2. The goal is not to minimize medication, but to minimize cardiovascular risk while maintaining quality of life. Only reduce medications if there are clear, documented adverse effects directly attributable to the drugs, not simply because BP is well-controlled.